Early Prostate Cancer Screening Improves Survival Odds
New York doctors recommend PSA tests to detect prostate cancer early, improving treatment options for men.
Updated on Oct. 8, 2026 in Cancer
Live Poll
Do you make it a priority to stay up-to-date with your recommended health screenings?
Prostate cancer affects 1 in 8 men, according to American Cancer Society projections. New York City medical experts emphasize that early screening is a vital step toward catching the disease when it is most treatable.
Why it matters
Early detection significantly improves survival rates and increases the range of available treatment options for patients. Regular screening is particularly critical as Black men face the highest prostate cancer death rates of any racial group.
The American Cancer Society projects that 1 in 8 men will receive a prostate cancer diagnosis. A PSA blood test is used to measure protein levels in prostate tissue, with levels exceeding 4.0 ng/mL considered abnormal.
The players
American Cancer Society
A national health organization that provides data on cancer incidence and advocates for early screening and prevention.
New York Proton Center
The only facility in New York State specializing in proton therapy for cancer treatment, located in East Harlem.
Lamont Mitchell
A patient who received a prostate cancer diagnosis in 2023.
The details
Physicians use the prostate-specific antigen (PSA) blood test to identify elevated protein levels that may indicate cancerous activity in the prostate tissue. For patients requiring intervention, the New York Proton Center in East Harlem offers advanced proton therapy. This facility remains the only site in New York State providing this targeted treatment, which directs radiation to the tumor while sparing surrounding healthy tissue.
Timeline
Lamont Mitchell was diagnosed with prostate cancer in 2023.
Health Landscape
Current prostate cancer management relies on early detection to shift the clinical paradigm away from late-stage intervention. This approach aligns with the American Cancer Society prostate cancer incidence projections, which highlight the necessity for proactive population-level monitoring.
Men should discuss their risk factors and the appropriateness of a PSA test with their primary care physician. If a screening reveals an abnormal level above 4.0 ng/mL, further diagnostic steps are required to determine the best course of action.
The takeaway
Early screening is the most effective tool for managing prostate cancer risk and improving treatment outcomes. Consult your physician about your personal health history to determine when to begin regular PSA blood tests.
Further reading
For more information on current protocols, visit Cancer.
Source note: This article includes information reported by CBS News.
Live Poll
Do you make it a priority to stay up-to-date with your recommended health screenings?
